| Ms Rita Solorzano, MA, CCC-SLP | |
|
1875 Connecticut Ave Nw Fl 10, Washington, DC 20009-6046 | |
| (202) 743-0840 | |
| Not Available |
| Full Name | Ms Rita Solorzano |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1875 Connecticut Ave Nw Fl 10, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023622677 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP000029 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rita Solorzano, MA, CCC-SLP 4801 Connecticut Ave Nw Apt 721, Washington, DC 20008-2206 Ph: (202) 743-0840 | Ms Rita Solorzano, MA, CCC-SLP 1875 Connecticut Ave Nw Fl 10, Washington, DC 20009-6046 Ph: (202) 743-0840 |
News Archive
An Australian initiative is successfully helping emergency doctors and nurses develop better treatments, diagnostics and services for improving patient care.
In a genetic engineering breakthrough that could help everyone from bed-ridden patients to elite athletes, a team of American researchers - including 2007 Nobel Prize winner Mario R. Capecchi - have created a "switch" that allows mutations or light signals to be turned on in muscle stem cells to monitor muscle regeneration in a living mammal
The Washington Post: Rapid growth in the number of applicants for Social Security disability benefits has soared between 2008 and 2009, threatening the solvency of the program. With an increase of 21 percent in that timeframe, "growth is the sharpest in the 54-year history of the program. It threatens the program's fiscal stability and adds to an administrative backlog that is slowing the flow of benefits to those who need them most." Broad economic problems and a flood of jobless applicants have caused the spike (Fletcher, 9/14).
ImThera Medical, Inc. today announced that it has concluded its Phase I and Phase II protocols for the European Pilot study of the aura6000, a neurostimulation device for treating Obstructive Sleep Apnea (OSA). Clinical trial results from the study will be announced at the American Thoracic Society's International Conference on May 16, 2011 in Denver, CO.
› Verified 2 days ago
Sheryl Jacob Desbordes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-4424 | |
Karen Garrido-nag, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Speech, Language And Hearing Sciences, Washington, DC 20002 Phone: 202-448-6964 Fax: 202-448-5324 | |
Voicetrainer, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Pennsylvania Ave Nw, Suite 300, Washington, DC 20006 Phone: 202-580-6646 Fax: 202-580-6559 | |
Samantha Wasilus, M.S CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4880 Macarthur Blvd Nw, Washington, DC 20007 Phone: 202-333-1403 Fax: 202-333-1404 | |
Tahera Sparks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Connecticut Ave Nw # 100, Washington, DC 20008 Phone: 202-525-1641 | |
Sydney Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Massachusetts Ave Ne Ste C9, Washington, DC 20002 Phone: 202-544-5469 | |
Joyce Doyle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3009 5th St Se, Washington, DC 20032 Phone: 571-221-2840 |